Global Prostate Specific Antigen (PSA) Biomarker Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 326987
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Prostate Specific Antigen (PSA) Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Prostate Specific Antigen (PSA) Biomarker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diagnostics accounting for % of the Prostate Specific Antigen (PSA) Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Blood segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Prostate Specific Antigen (PSA) Biomarker include Abbott, Siemens Healthcare, DiaSorin, Roche, and Tosoh Bioscience, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Prostate Specific Antigen (PSA) Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Blood

Semen

Urine

Market segment by Application, can be divided into

Diagnostics

Drug Discovery

Personalized Medicine

Others

Market segment by players, this report covers

Abbott

Siemens Healthcare

DiaSorin

Roche

Tosoh Bioscience

Fujirebio

BodiTech

GE Healthcare

Endocare

Quest Diagnostics

Bio-Rad Laboratories

QIAGEN

Myriad RBM

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Prostate Specific Antigen (PSA) Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Prostate Specific Antigen (PSA) Biomarker, with revenue, gross margin and global market share of Prostate Specific Antigen (PSA) Biomarker from 2019 to 2022.

Chapter 3, the Prostate Specific Antigen (PSA) Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Specific Antigen (PSA) Biomarker market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Prostate Specific Antigen (PSA) Biomarker research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Biomarker

1.2 Classification of Prostate Specific Antigen (PSA) Biomarker by Type

1.2.1 Overview: Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type in 2021

1.2.3 Blood

1.2.4 Semen

1.2.5 Urine

1.3 Global Prostate Specific Antigen (PSA) Biomarker Market by Application

1.3.1 Overview: Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Global Prostate Specific Antigen (PSA) Biomarker Market Size & Forecast

1.5 Global Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast by Region

1.5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region, (2017-2022)

1.5.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2017-2028)

1.5.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2017-2028)

1.5.6 South America Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate Specific Antigen (PSA) Biomarker Market Drivers

1.6.2 Prostate Specific Antigen (PSA) Biomarker Market Restraints

1.6.3 Prostate Specific Antigen (PSA) Biomarker Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.1.4 Abbott Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Siemens Healthcare

2.2.1 Siemens Healthcare Details

2.2.2 Siemens Healthcare Major Business

2.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.2.4 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Siemens Healthcare Recent Developments and Future Plans

2.3 DiaSorin

2.3.1 DiaSorin Details

2.3.2 DiaSorin Major Business

2.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.3.4 DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 DiaSorin Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.4.4 Roche Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Roche Recent Developments and Future Plans

2.5 Tosoh Bioscience

2.5.1 Tosoh Bioscience Details

2.5.2 Tosoh Bioscience Major Business

2.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.5.4 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Tosoh Bioscience Recent Developments and Future Plans

2.6 Fujirebio

2.6.1 Fujirebio Details

2.6.2 Fujirebio Major Business

2.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.6.4 Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Fujirebio Recent Developments and Future Plans

2.7 BodiTech

2.7.1 BodiTech Details

2.7.2 BodiTech Major Business

2.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.7.4 BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 BodiTech Recent Developments and Future Plans

2.8 GE Healthcare

2.8.1 GE Healthcare Details

2.8.2 GE Healthcare Major Business

2.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.8.4 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 GE Healthcare Recent Developments and Future Plans

2.9 Endocare

2.9.1 Endocare Details

2.9.2 Endocare Major Business

2.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.9.4 Endocare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Endocare Recent Developments and Future Plans

2.10 Quest Diagnostics

2.10.1 Quest Diagnostics Details

2.10.2 Quest Diagnostics Major Business

2.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.10.4 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Quest Diagnostics Recent Developments and Future Plans

2.11 Bio-Rad Laboratories

2.11.1 Bio-Rad Laboratories Details

2.11.2 Bio-Rad Laboratories Major Business

2.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.11.4 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.12 QIAGEN

2.12.1 QIAGEN Details

2.12.2 QIAGEN Major Business

2.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.12.4 QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 QIAGEN Recent Developments and Future Plans

2.13 Myriad RBM

2.13.1 Myriad RBM Details

2.13.2 Myriad RBM Major Business

2.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product and Solutions

2.13.4 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Myriad RBM Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate Specific Antigen (PSA) Biomarker Players Market Share in 2021

3.2.2 Top 10 Prostate Specific Antigen (PSA) Biomarker Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Prostate Specific Antigen (PSA) Biomarker Players Head Office, Products and Services Provided

3.4 Prostate Specific Antigen (PSA) Biomarker Mergers & Acquisitions

3.5 Prostate Specific Antigen (PSA) Biomarker New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue and Market Share by Type (2017-2022)

4.2 Global Prostate Specific Antigen (PSA) Biomarker Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2017-2022)

5.2 Global Prostate Specific Antigen (PSA) Biomarker Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2028)

6.2 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2028)

6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country

6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2028)

6.3.2 United States Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

6.3.3 Canada Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

6.3.4 Mexico Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2028)

7.2 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2028)

7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country

7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2028)

7.3.2 Germany Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

7.3.3 France Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

7.3.5 Russia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

7.3.6 Italy Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2028)

8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2028)

8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region

8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2017-2028)

8.3.2 China Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8.3.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8.3.4 South Korea Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8.3.5 India Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

8.3.7 Australia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2028)

9.2 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2028)

9.3 South America Prostate Specific Antigen (PSA) Biomarker Market Size by Country

9.3.1 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2028)

9.3.2 Brazil Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

9.3.3 Argentina Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2028)

10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2028)

10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country

10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2028)

10.3.2 Turkey Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

10.3.4 UAE Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Prostate Specific Antigen (PSA) Biomarker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Region (2017-2022)

Table 5. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2023-2028)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 9. Abbott Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Siemens Healthcare Corporate Information, Head Office, and Major Competitors

Table 11. Siemens Healthcare Major Business

Table 12. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 13. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. DiaSorin Corporate Information, Head Office, and Major Competitors

Table 15. DiaSorin Major Business

Table 16. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 17. DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 21. Roche Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Tosoh Bioscience Corporate Information, Head Office, and Major Competitors

Table 23. Tosoh Bioscience Major Business

Table 24. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 25. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Fujirebio Corporate Information, Head Office, and Major Competitors

Table 27. Fujirebio Major Business

Table 28. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 29. Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. BodiTech Corporate Information, Head Office, and Major Competitors

Table 31. BodiTech Major Business

Table 32. BodiTech Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 33. BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 35. GE Healthcare Major Business

Table 36. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 37. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Endocare Corporate Information, Head Office, and Major Competitors

Table 39. Endocare Major Business

Table 40. Endocare Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 41. Endocare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 43. Quest Diagnostics Major Business

Table 44. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 45. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Bio-Rad Laboratories Major Business

Table 48. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 49. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. QIAGEN Corporate Information, Head Office, and Major Competitors

Table 51. QIAGEN Major Business

Table 52. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 53. QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Myriad RBM Corporate Information, Head Office, and Major Competitors

Table 55. Myriad RBM Major Business

Table 56. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product and Solutions

Table 57. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Prostate Specific Antigen (PSA) Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Prostate Specific Antigen (PSA) Biomarker Players Head Office, Products and Services Provided

Table 62. Prostate Specific Antigen (PSA) Biomarker Mergers & Acquisitions in the Past Five Years

Table 63. Prostate Specific Antigen (PSA) Biomarker New Entrants and Expansion Plans

Table 64. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Type (2017-2022)

Table 65. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Type (2017-2022)

Table 66. Global Prostate Specific Antigen (PSA) Biomarker Revenue Forecast by Type (2023-2028)

Table 67. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022)

Table 68. Global Prostate Specific Antigen (PSA) Biomarker Revenue Forecast by Application (2023-2028)

Table 69. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Prostate Specific Antigen (PSA) Biomarker Picture

Figure 2. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type in 2021

Figure 3. Blood

Figure 4. Semen

Figure 5. Urine

Figure 6. Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application in 2021

Figure 7. Diagnostics Picture

Figure 8. Drug Discovery Picture

Figure 9. Personalized Medicine Picture

Figure 10. Others Picture

Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2017-2028)

Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region in 2021

Figure 15. North America Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Prostate Specific Antigen (PSA) Biomarker Market Drivers

Figure 21. Prostate Specific Antigen (PSA) Biomarker Market Restraints

Figure 22. Prostate Specific Antigen (PSA) Biomarker Market Trends

Figure 23. Abbott Recent Developments and Future Plans

Figure 24. Siemens Healthcare Recent Developments and Future Plans

Figure 25. DiaSorin Recent Developments and Future Plans

Figure 26. Roche Recent Developments and Future Plans

Figure 27. Tosoh Bioscience Recent Developments and Future Plans

Figure 28. Fujirebio Recent Developments and Future Plans

Figure 29. BodiTech Recent Developments and Future Plans

Figure 30. GE Healthcare Recent Developments and Future Plans

Figure 31. Endocare Recent Developments and Future Plans

Figure 32. Quest Diagnostics Recent Developments and Future Plans

Figure 33. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 34. QIAGEN Recent Developments and Future Plans

Figure 35. Myriad RBM Recent Developments and Future Plans

Figure 36. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players in 2021

Figure 37. Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Prostate Specific Antigen (PSA) Biomarker Revenue Market Share in 2021

Figure 39. Global Top 10 Players Prostate Specific Antigen (PSA) Biomarker Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Type in 2021

Figure 42. Global Prostate Specific Antigen (PSA) Biomarker Market Share Forecast by Type (2023-2028)

Figure 43. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application in 2021

Figure 44. Global Prostate Specific Antigen (PSA) Biomarker Market Share Forecast by Application (2023-2028)

Figure 45. North America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2017-2028)

Figure 46. North America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2017-2028)

Figure 47. North America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2017-2028)

Figure 48. United States Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2017-2028)

Figure 52. Europe Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2017-2028)

Figure 53. Europe Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2017-2028)

Figure 54. Germany Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2017-2028)

Figure 62. China Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2017-2028)

Figure 69. South America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2017-2028)

Figure 70. South America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz